BMC Infectious Diseases (Jan 2021)

Acute cardiovascular events in patients with community acquired pneumonia: results from the observational prospective FADOI-ICECAP study

  • Filippo Pieralli,
  • Vieri Vannucchi,
  • Carlo Nozzoli,
  • Giuseppe Augello,
  • Francesco Dentali,
  • Giulia De Marzi,
  • Generoso Uomo,
  • Filippo Risaliti,
  • Laura Morbidoni,
  • Antonino Mazzone,
  • Claudio Santini,
  • Daniela Tirotta,
  • Francesco Corradi,
  • Riccardo Gerloni,
  • Paola Gnerre,
  • Gualberto Gussoni,
  • Antonella Valerio,
  • Mauro Campanini,
  • Dario Manfellotto,
  • Andrea Fontanella,
  • for the FADOI-ICECAP Study Group

DOI
https://doi.org/10.1186/s12879-021-05781-w
Journal volume & issue
Vol. 21, no. 1
pp. 1 – 12

Abstract

Read online

Abstract Background The burden of cardiovascular (CV) complications in patients hospitalised for community-acquired pneumonia (CAP) is still uncertain. Available studies used different designs and different criteria to define CV complications. We assessed the cumulative incidence of acute of CV complications during hospitalisation for CAP in Internal Medicine Units (IMUs). Methods This was a prospective study carried out in 26 IMUs, enrolling patients consecutively hospitalised for CAP. Defined CV complications were: newly diagnosed heart failure, acute coronary syndrome, new onset of supraventricular or ventricular arrhythmias, new onset hemorrhagic or ischemic stroke or transient ischemic attack. Outcome measures were: in-hospital and 30-day mortality, length of hospital stay and rate of 30-day re-hospitalisation. Results A total of 1266 patients were enrolled, of these 23.8% experienced at least a CV event, the majority (15.5%) represented by newly diagnosed decompensated heart failure, and 75% occurring within 3 days. Female gender, a history of CV disease, and more severe pneumonia were predictors of CV events. In-hospital (12.2% vs 4.7%, p < 0.0001) and 30-day (16.3% vs 8.9%, p = 0.0001) mortality was higher in patients with CV events, as well as the re-hospitalisation rate (13.3% vs 9.3%, p = 0.002), and mean hospital stay was 11.4 ± 6.9 vs 9.5 ± 5.6 days (p < 0.0001). The occurrence of CV events during hospitalisation significantly increased the risk of 30-day mortality (HR 1.69, 95% CI 1.14–2.51; p = 0.009). Conclusion Cardiovascular events are frequent in CAP, and their occurrence adversely affects outcome. A strict monitoring might be useful to intercept in-hospital CV complications for those patients with higher risk profile. Trial registration NCT03798457 Registered 10 January 2019 - Retrospectively registered

Keywords